Cogent Biosciences (COGT): Assessing Valuation After a 94% Year-to-Date Share Price Surge [Yahoo! Finance]
Cogent Biosciences, Inc. (COGT)
Last cogent biosciences, inc. earnings: 11/8 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.cogint.com/investor-relations
Company Research
Source: Yahoo! Finance
company's recent performance invites a closer look at what is driving investor interest. See our latest analysis for Cogent Biosciences. After surging nearly 94% in share price this year, Cogent Biosciences is clearly attracting attention, even with some recent volatility. The latest gain of 1.95% in the past day follows a notable 14% rise over the last month, which hints that momentum is building. Looking at the bigger picture, its one-year total shareholder return of 26.4% suggests that many investors who stuck with the stock have seen solid progress, both in the short and longer term. If fresh biotech momentum has you wondering what else is out there, consider this a great chance to explore a broader universe. Discover See the full list for free. But with shares having more than doubled and trading about 44% below analyst targets, is this the perfect moment to buy in before the next move higher? Or is the market already expecting strong future growth? Price-to-Book Ratio
Show less
Read more
Impact Snapshot
Event Time:
COGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COGT alerts
High impacting Cogent Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
COGT
News
- Cogent Biosciences (NASDAQ:COGT) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress [Yahoo! Finance]Yahoo! Finance
- Cogent Biosciences Announces Participation in the Jefferies Global Healthcare ConferenceGlobeNewswire
- Cogent Biosciences (NASDAQ:COGT) had its price target raised by analysts at HC Wainwright from $21.00 to $50.00. They now have a "buy" rating on the stock.MarketBeat
- Cogent Biosciences (COGT) Is Up 144.5% After Bezuclastinib Phase 3 Win and $500M Capital Raise Has The Bull Case Changed? [Yahoo! Finance]Yahoo! Finance
COGT
Sec Filings
- 11/18/25 - Form 8-K
- 11/17/25 - Form SCHEDULE
- 11/14/25 - Form SCHEDULE
- COGT's page on the SEC website